Company News: Page (1) of 1 - 01/11/17

Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair

- Merck KGaA, Darmstadt, Germany licenses two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs- All programs have first-in-class and best-in-class...

January 11, 2017 -- !-- AddToAny BEGIN -->
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords:Home,Family,Family,Communications,Smart Phone,Germany,USA, Inc.,Medicine,healthcare,Surgery,Science,Lifestyle,Medical,Biology,Genetics,Cancer,Business,Science,Email,Family,Other,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved